Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Soledad Negrotto(Pfizer (United States)), Yogen Saunthararajah(Cleveland Clinic)
Cited by 33
Related Papers
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
|Journal of Clinical Investigation|2018|117
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
|Blood|2011|100
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
|Journal of Clinical Investigation|2017|49
Activation of cyclic AMP pathway prevents CD34+ cell apoptosis
|Experimental Hematology|2006|25